Recent Company News

• 04:16 AM ET Jul 20, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:34 AM ET Aug 13, 2026
  

  Evotec confirms prelim Q2/H1 earnings and FY26 guidance as per 13-Jul update (€3.85, 0.00)

• 02:17 AM ET Aug 06, 2026
  

  Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

• 01:38 AM ET Aug 06, 2026
  

  Evotec and Odyssey Therapeutics enter AI-Enabled R&D collaboration in autoimmune and Inflammatory diseases (€3.43, 0.00)

• 08:36 AM ET Aug 03, 2026
  

  Niagen Bioscience selects Evotec to advance preclinical development for NB4168 ($3.40, 0.00)

• 10:00 AM ET Jul 22, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (79 total)

• 06:18 PM ET Jul 16, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:56 AM ET Jul 16, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market